BioSpace News Archive

Drug Development

Verastem Oncology Announces Presentation of Preclinical Data Supporting Dual PI3K-delta and PI3K-gamma Inhibition in Combination with Immunotherapy at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Verastem, Inc. today announced a poster presentation of preclinical data by Jonathan Pachter, Ph.D., the Company’s Chief Scientific Officer, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting being held November 7-11, 2018, in Washington, D.C.

November 6, 2018
·
6 min read
Business

Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance

Third-quarter 2018 revenue increased 7 percent, driven primarily by increased demand for new medicines, while operating expenses increased 1 percent.

November 6, 2018
·
37 min read
Business

Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress

FDA Advisory Committee Meeting outcome supports approval of ZULRESSO™ (brexanolone) injection as the first medicine specifically indicated for the treatment of postpartum depression (PPD)

November 6, 2018
·
15 min read
Sectra to Provide Vendor-neutral Platform for Medical Imaging AI Project in the UK

International medical imaging IT and cybersecurity company Sectra will provide its vendor-neutral platform for AI to the consortium NPIC.

November 6, 2018
·
3 min read
Job Trends

Nova Medical Centers Announces Game Changing Technology Upgrade

Nova Medical Centers announces today a game changing technology update to their proprietary electronic medical record system, Occuflex.

November 6, 2018
·
1 min read
Business

Five Prime Therapeutics Announces Third Quarter 2018 Financial Results

Initiated Phase 3 FIGHT global registrational trial of bemarituzumab in gastric and gastroesophageal junction (GEJ) cancer

November 6, 2018
·
13 min read
Business

Diplomat Announces 3rd Quarter Financial Results

Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation’s largest independent provider of specialty pharmacy services, announced financial results for the quarter ended September 30, 2018.

November 6, 2018
·
116 min read
Biotech Bay

4D Molecular Therapeutics to Participate at Upcoming Investor Conferences

4D Molecular Therapeutics (4DMT), a world-leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product development today announced that company management will participate at the following upcoming investor conferences:

November 6, 2018
·
2 min read
Business

Quidel Reports Third Quarter 2018 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2018.

November 6, 2018
·
21 min read
Business

Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported its financial results for the third quarter ended September 30, 2018, and provided a corporate update on its clinical development programs.

November 6, 2018
·
9 min read